This finding is consistent with the notion that cortical Aβ deposition precedes neocortical tau aggregation [34] and with previous studies reporting that the decrease in CSF Aβ42/Aβ40 ratio is followed by a large increase in CSF p-tau also in preclinical AD patients [42]. Here, MAPT is linked to Alzheimer disease.